“Occupational diseases, asthma and pulmonary interstitium lung disease”.
Coordinator: Ferran Morell Brotard.
The Group is considered a referral team for the diagnosis of work-related lung diseases in Catalonia, centering on occupational asthma, hypersensitivity pneumonitis, and occupational disease caused by asbestos exposure. It is responsible of the Spanish Registry of Occupational Diseases and it is an accredited center to carry out determinations of environmental levels of soy allergens in Barcelona.
“Respiratory infections and molecular biology ”.
Coordinator: Javier de Gracia Roldán.
The Group has a dedicated outpatient care center for primary immunodeficiency and is the referral center for this disease. There is also a Catalonia Referral Unit for Cystic Fibrosis, which maintains the Spanish registry of bronchiectasis and patients with a1-antitrypsin deficit. Moreover, the team is considered to be expert in the control of tuberculous disease.
”Lung transplant and lung hypertension”.
Coordinator: Antonio Román Broto.
The Group performed the first successful lung transplantation in Spain. It is one of the hospitals where the largest number of lung transplants are carried out annually, which places it among the leading centers in Europe. The objectives in lung transplantation are centered on the TRANSEPOC project, in which the correlation between structure and function will be investigated in advanced COPD.
“Study of the chronic obstructive pulmonary disease (COPD) and pleura pathology ”.
Coordinator: Jaume Ferrer Sancho.
The research has centered on genetic aspects of the disease on patents with emphysema due to a-1 antitrypsin deficit and exacerbation of COPD. There are one multicenter project designed to determine phenotype variability in COPD and another anatomical-functional correlation study in patients with severe COPD. A research line has been initiated based on the study of inflammation in lung tissue.
“Respiratory sleep disorders “.
Coordinator: Gabriel Sampol Rubio.
The research focuses on the diagnostic and therapeutic options for respiratory sleep disorders, and, on the vascular repercussions of these disorders. The Group is participating in multicenter endeavors in non-invasive mechanical ventilation and in a project to assess the efficacy of treatment with continuous positive air pressure (CPAP) through a nasal route to reduce arterial pressure values.